This association was further validated in the TCGA-BLCA and Japanese UTUC cohorts, where the basal subtype showed significantly enhanced CXCL10 expression and a greater number of tumor-infiltrating CD8+ T cells and macrophages (Supplementary Figure S5D). The gene discussed is CXCL10; the disease is renal pelvis/ureter urothelial carcinoma.